Dynamic modulations of urinary sphingolipid and glycerophospholipid levels in COVID-19 and correlations with COVID-19-associated kidney injuries

[1]  H. Hashimoto,et al.  Dynamic modulations of sphingolipids and glycerophospholipids in COVID‐19 , 2022, Clinical and translational medicine.

[2]  H. Jun,et al.  Inhibition of ChREBP ubiquitination via the ROS/Akt-dependent downregulation of Smurf2 contributes to lysophosphatidic acid-induced fibrosis in renal mesangial cells , 2022, Journal of biomedical science.

[3]  Patricia R S Rodrigues,et al.  The SARS-CoV2 envelope differs from host cells, exposes procoagulant lipids, and is disrupted in vivo by oral rinses , 2022, Journal of Lipid Research.

[4]  M. Kurano,et al.  Urine sediment findings were milder in patients with COVID-19-associated renal injuries than in those with non-COVID-19-associated renal injuries , 2022, International Journal of Infectious Diseases.

[5]  Y. Hannun,et al.  Neutral ceramidase deficiency protects against cisplatin-induced acute kidney injury , 2022, Journal of lipid research.

[6]  M. Nangaku,et al.  Lysophosphatidylcholine mediates fast decline in kidney function in diabetic kidney disease , 2021, Kidney International.

[7]  R. Gil-Redondo,et al.  Uneven metabolic and lipidomic profiles in recovered COVID‐19 patients as investigated by plasma NMR metabolomics , 2021, NMR in biomedicine.

[8]  M. Kurano,et al.  Increase in serum levels of phosphatidylserine-specific phospholipase A1 in COVID-19 patients , 2021, Cellular & Molecular Immunology.

[9]  L. Forni,et al.  Pathophysiology of COVID-19-associated acute kidney injury , 2021, Nature Reviews Nephrology.

[10]  J. Aoki,et al.  Current Knowledge on the Biology of Lysophosphatidylserine as an Emerging Bioactive Lipid , 2021, Cell Biochemistry and Biophysics.

[11]  A. Levin,et al.  High SARS-CoV-2 Viral Load in Urine Sediment Correlates with Acute Kidney Injury and Poor COVID-19 Outcome , 2021, Journal of the American Society of Nephrology : JASN.

[12]  M. Kurano,et al.  Lysophosphatidylinositol, especially albumin‐bound form, induces inflammatory cytokines in macrophages , 2021, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  D. Im,et al.  2-Arachidonyl-lysophosphatidylethanolamine Induces Anti-Inflammatory Effects on Macrophages and in Carrageenan-Induced Paw Edema , 2021, International journal of molecular sciences.

[14]  H. Tun,et al.  Multi-platform omics analysis reveals molecular signature for COVID-19 pathogenesis, prognosis and drug target discovery , 2021, Signal Transduction and Targeted Therapy.

[15]  P. Oefner,et al.  Urine Metabolite Levels, Adverse Kidney Outcomes, and Mortality in CKD Patients: A Metabolome-wide Association Study. , 2021, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  F. Wilson,et al.  Assessment of Acute Kidney Injury and Longitudinal Kidney Function After Hospital Discharge Among Patients With and Without COVID-19 , 2021, JAMA network open.

[17]  Fan Yang,et al.  Plasma Metabolomic Profiling of Patients Recovered From Coronavirus Disease 2019 (COVID-19) With Pulmonary Sequelae 3 Months After Discharge , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  A. Fornoni,et al.  Sphingosine-1-Phosphate Metabolism and Signaling in Kidney Diseases. , 2020, Journal of the American Society of Nephrology : JASN.

[19]  M. Abate,et al.  Outcomes Among Patients Hospitalized With COVID-19 and Acute Kidney Injury , 2020, American Journal of Kidney Diseases.

[20]  B. Lambermont,et al.  Proteinuria in COVID-19: prevalence, characterization and prognostic role , 2020, Journal of Nephrology.

[21]  M. Kurano,et al.  Clot waveform of APTT has abnormal patterns in subjects with COVID-19 , 2020, Scientific reports.

[22]  S. Summers,et al.  Rotten to the Cortex: Ceramide-Mediated Lipotoxicity in Diabetic Kidney Disease , 2021, Frontiers in Endocrinology.

[23]  G. Hassanzadeh,et al.  Combination therapy of phosphatidylserine liposome with cyclosporine A improves nephrotoxicity and attenuates delayed-type hypersensitivity response. , 2020, Life sciences.

[24]  M. Sugiyama,et al.  Evaluation of Coronavirus Disease 2019 Severity Using Urine Biomarkers , 2020, Critical care explorations.

[25]  J. Lacy,et al.  Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series , 2020, The Lancet.

[26]  K. Miyazono,et al.  Nafamostat mesylate treatment in combination with favipiravir for patients critically ill with Covid-19: a case series , 2020, Critical Care.

[27]  M. Kurano,et al.  Urinary autotaxin concentrations are associated with kidney injury. , 2020, Clinica chimica acta; international journal of clinical chemistry.

[28]  É. Azoulay,et al.  Acute kidney injury in critically ill patients with COVID-19 , 2020, Intensive Care Medicine.

[29]  N. Ohmagari,et al.  Cautious handling of urine from moderate to severe COVID-19 patients , 2020, American Journal of Infection Control.

[30]  M. Kurano,et al.  Establishment of a Measurement System for Sphingolipids in the Cerebrospinal Fluid Based on Liquid Chromatography-Tandem Mass Spectrometry, and Its Application in the Diagnosis of Carcinomatous Meningitis. , 2020, The journal of applied laboratory medicine.

[31]  Kenar D. Jhaveri,et al.  Acute kidney injury in patients hospitalized with COVID-19 , 2020, Kidney International.

[32]  Holger Moch,et al.  Endothelial cell infection and endotheliitis in COVID-19 , 2020, The Lancet.

[33]  Youdong Wei,et al.  Changes in blood coagulation in patients with severe coronavirus disease 2019 (COVID‐19): a meta‐analysis , 2020, British journal of haematology.

[34]  Xiu-Wu Pan,et al.  Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis , 2020, Intensive Care Medicine.

[35]  A. Sahebkar,et al.  The role of phosphatidylserine recognition receptors in multiple biological functions , 2020, Cellular & Molecular Biology Letters.

[36]  Lei Dong,et al.  Kidney disease is associated with in-hospital death of patients with COVID-19 , 2020, Kidney International.

[37]  W. Bollag,et al.  Pathogen-Associated Molecular Pattern-Induced TLR2 and TLR4 Activation Increases Keratinocyte Production of Inflammatory Mediators and is Inhibited by Phosphatidylglycerol , 2020, Molecular Pharmacology.

[38]  G. Herrler,et al.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.

[39]  M. Kurano,et al.  Analysis of urinary sphingolipids using liquid chromatography‐tandem mass spectrometry in diabetic nephropathy , 2019, Journal of Diabetes Investigation.

[40]  M. Kurano,et al.  Evaluation of Lysophospholipid Measurement in Cerebrospinal Fluid Samples using Liquid Chromatography-Tandem Mass Spectrometry. , 2019, Lipids.

[41]  M. Kurano,et al.  Redox state of albumin affects its lipid mediator binding characteristics , 2019, Free radical research.

[42]  H. Jun,et al.  Lysophosphatidic acid receptor 1 inhibitor, AM095, attenuates diabetic nephropathy in mice by downregulation of TLR4/NF-κB signaling and NADPH oxidase. , 2019, Biochimica et biophysica acta. Molecular basis of disease.

[43]  K. Tsuneyama,et al.  Apolipoprotein M suppresses the phenotypes of IgA nephropathy in hyper‐IgA mice , 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[44]  P. J. Larsen,et al.  The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach , 2019, Molecular metabolism.

[45]  M. Kurano,et al.  Analysis of Urinary Sphingolipids using LC-MS/MS in Diabetic Nephropathy. , 2019, Journal of diabetes investigation.

[46]  M. Kurano,et al.  Lysophospholipids in laboratory medicine , 2018, Proceedings of the Japan Academy. Series B, Physical and biological sciences.

[47]  A. Llorente,et al.  Exosomal lipid composition and the role of ether lipids and phosphoinositides in exosome biology , 2018, Journal of Lipid Research.

[48]  K. Tsuneyama,et al.  Apolipoprotein M Protects Lipopolysaccharide-Treated Mice from Death and Organ Injury , 2018, Thrombosis and Haemostasis.

[49]  M. Kurano,et al.  Sphingosine 1-Phosphate and Atherosclerosis , 2018, Journal of atherosclerosis and thrombosis.

[50]  S. Hadjadj,et al.  Urinary lysophopholipids are increased in diabetic patients with nephropathy. , 2017, Journal of diabetes and its complications.

[51]  J. Schanstra,et al.  Lysophosphatidic Acid Protects Against Endotoxin-Induced Acute Kidney Injury , 2017, Inflammation.

[52]  J. Chun,et al.  Lysophosphatidic acid signaling through its receptor initiates profibrotic epithelial cell fibroblast communication mediated by epithelial cell derived connective tissue growth factor. , 2017, Kidney international.

[53]  H. Ye,et al.  Sphingosine 1-phosphate receptor-1 enhances mitochondrial function and reduces cisplatin-induced tubule injury. , 2015, Journal of the American Society of Nephrology : JASN.

[54]  P. D. Nagy,et al.  RNA virus replication depends on enrichment of phosphatidylethanolamine at replication sites in subcellular membranes , 2015, Proceedings of the National Academy of Sciences.

[55]  Tao Wang,et al.  Changes of urinary phospholipids in the chronic kidney disease patients , 2013, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[56]  J. Jeong,et al.  Protective role of phosphatidylcholine against cisplatin-induced renal toxicity and oxidative stress in rats. , 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[57]  S. Higashiyama,et al.  TGFα shedding assay: an accurate and versatile method for detecting GPCR activation , 2012, Nature Methods.

[58]  J. Hampe,et al.  Hepatitis B virus–induced lipid alterations contribute to natural killer T cell–dependent protective immunity , 2012, Nature Medicine.

[59]  K. Brown,et al.  Inhibition of sphingosine 1-phosphate receptor 2 protects against renal ischemia-reperfusion injury. , 2012, Journal of the American Society of Nephrology : JASN.

[60]  V. D’Agati,et al.  Sphingosine kinase 1 protects against renal ischemia-reperfusion injury in mice by sphingosine-1-phosphate1 receptor activation. , 2011, Kidney international.

[61]  Rong-jun Chen,et al.  Evaluation of sphingolipid metabolism in renal cortex of rats with streptozotocin-induced diabetes and the effects of rapamycin. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[62]  E. Ravussin,et al.  The NALP3/NLRP3 Inflammasome Instigates Obesity-Induced Autoinflammation and Insulin Resistance , 2010, Nature Medicine.

[63]  A. Yamashita,et al.  2-Arachidonoyl-sn-glycero-3-phosphoinositol: a possible natural ligand for GPR55. , 2008, Journal of biochemistry.

[64]  Kubilay Gürünlüoğlu,et al.  Polyenylphosphatidylcholine pretreatment ameliorates ischemic acute renal injury in rats , 2006, International journal of urology : official journal of the Japanese Urological Association.

[65]  T. Yano,et al.  Involvement of de novo ceramide synthesis in radiocontrast-induced renal tubular cell injury. , 2006, Kidney international.

[66]  Sudhir V. Shah,et al.  Ceramide synthase is essential for endonuclease-mediated death of renal tubular epithelial cells induced by hypoxia-reoxygenation. , 2005, American journal of physiology. Renal physiology.

[67]  W. Buurman,et al.  Lysophosphatidic acid prevents renal ischemia-reperfusion injury by inhibition of apoptosis and complement activation. , 2003, The American journal of pathology.

[68]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[69]  M. Maceyka,et al.  Sphingosine kinase, sphingosine-1-phosphate, and apoptosis. , 2002, Biochimica et biophysica acta.

[70]  R. Zager,et al.  Altered sphingomyelinase and ceramide expression in the setting of ischemic and nephrotoxic acute renal failure. , 1998, Kidney international.

[71]  Y. Hannun,et al.  Programmed cell death induced by ceramide. , 1993, Science.